Johnson, J. S., Fishman, M. N., Schell, M. J., Yu, X., Wang, X., Souza, G. R., Miller, J., Mizelle, S. R., Gullapalli, K., Fazili, A. N., Guske, C., Mannam, G., Jameel, G., Cen, L., Yao, J., Whiting, J., Swank, J., Zhang, J., Spiess, P. E., Chahoud, J. (2025). Updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.554